Harry, just sign up for the free trial on-line.
Anyways it was also interesting that Rob mentioned, due to the Chinese subsidiary, margins have now doubled and USCOM1A sales numbers have increased.
In addition, Rob and his team seem to be quite innovative, so far as, considering whether other companies that are 'novel and high commercial value' by buying them or share profits and distribution into our pathway. I found this statement to be quite exciting as the opportunities would be quite substantial for the newly established distribution network one would imagine.
I also found it particularly interesting that Rob made references to CSL, ResMed and Cochlear whilst talking about... "The opportunities for growth are quite astounding".
Keeping in mind the distribution network in China, new products due in second half of this year, and once USA and Europe are all up and running it definitely appears that we are at a major inflection point and this co. is potentially heading for considerable growth phases.
Bring on the 4C and the PLA tenders!!!!GLTAH
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable